brentuximab vedotin
seagen,takeda
['lymsm', 'improve', 'hodgkin']
the long awaited os follow up results of the #echelon1 in hodgkin #lymsm showing improved os. a practice changing update! #asco22 
A hematologist @MoffittNews with interest in #lymsm. Tweets are not endorsements, and not medical advice.